Last edition
News about "monoclonal antibodies "
Aragen Introduces CHOMax for Rapid IND-Enabling Clinical Supply
Aragen has launched CHOMax, a fully integrated and royalty-free platform designed to accelerate the journey from DNA to IND-enabling clinical supply in approximately 10 months, combining cell line development, process and analytical development and GMP manufacturing with demonstrated high-performance outcomes.
Monoclonal Antibodies | 13/01/2026 | By News Bureau
ScinoPharm Wins FDA Approval for Glatiramer Acetate Injection
ScinoPharm Taiwan has received US FDA approval for its Glatiramer Acetate Injection for the treatment of multiple sclerosis, marking a significant milestone as the first and only Taiwanese pharmaceutical company to secure FDA approval for this complex generic, and reinforcing Taiwan’s growing role in the global pharmaceutical supply chain.
Monoclonal Antibodies | 05/01/2026 | By News Bureau
Four Drugs in Race for First Bispecific ADC Approval: GlobalData
With 21 global approvals, ADCs generated USD 13.6 billion in 2024. BsADCs represent further opportunities in this field, by leveraging bi-specific antibodies that simultaneously bind two distinct targets.
Monoclonal Antibodies | 02/09/2025 | By Dineshwori | 243
Axio BioPharma Introduces New Protein Manufacturing Services
Axio BioPharma specializes in research-grade manufacturing of monoclonal antibodies (mAbs), focusing on small-scale production ranging from 50?mL to 2?L.
Monoclonal Antibodies | 23/09/2024 | By Aishwarya | 425
Sanyou Bio Rolls Out Comprehensive Monkeypox Product Line
Developed using Sanyou Bio's proprietary 'over-trillion innovative antibody discovery' platform, the monoclonal antibodies span multiple species, including fully human, nano, and mouse antibodies.
Monoclonal Antibodies | 31/08/2024 | By Aishwarya | 486
Nona Biosciences Signs License Deal with AstraZeneca for Monoclonal Antibody Development
Nona Biosciences has signed a license deal with AstraZeneca for preclinical monoclonal antibodies that will be used to create targeted therapies in oncology.
Monoclonal Antibodies | 27/05/2024 | By Aishwarya | 369
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy